<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5535929</article-id><article-id pub-id-type="doi">10.3390/ijms18071438</article-id><article-id pub-id-type="publisher-id">ijms-18-01438</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Influence of the Periodontal Disease, the Most Prevalent Inflammatory Event, in Peroxisome Proliferator-Activated Receptors Linking Nutrition and Energy Metabolism</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rom&#225;n-Malo</surname><given-names>Lourdes</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bullon</surname><given-names>Pedro</given-names></name><xref rid="c1-ijms-18-01438" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-ijms-18-01438">Laboratorio de Investigacion, Departamento de Estomatologia, Universidad de Sevilla, c/ Avicena s/n, Sevilla 41009, Spain; <email>lvrmalo@gmail.com</email></aff><author-notes><corresp id="c1-ijms-18-01438"><label>*</label>Correspondence: <email>pbullon@us.es</email>; Tel.: +34-954-481-120</corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2017</year></pub-date><volume>18</volume><issue>7</issue><elocation-id>1438</elocation-id><history><date date-type="received"><day>27</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>28</day><month>6</month><year>2017</year></date></history><permissions><copyright-statement>&#169; 2017 by the authors.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Periodontal disease is considered one of the main pathologic diseases occurring in humans. Its pathologic process involves inflammatory reactions producing periodontal bone resorption and the tooth loss. But some patients do not present an evident clinical inflammation with bone resorption, and in others, the inflammation is prominent without bone resorption. A key question could be to investigate a different way of responding to aggression. Inflammation requires a complex intracellular metabolic process, starting with the harmful recognition and activation of the inflammasome, continues the energy supply with the alteration of oxidative stress conditions, and finishes with the elimination of the aggression with autophagy/apoptosis mechanisms, then concludes with recovery. Peroxisome proliferator-activated receptors (PPARs) are essential molecules produced in inflammation, and its genes and its activation have been related to periodontal disease. Also, an important aspect is the influence of PPARs in bone metabolism; the main periodontitis symptom is bone loss and PPAR&#947; activation that can downregulate the bone resorption in experimental periodontitis, PPAR&#947;-coated titanium dental implant surfaces could carry the antiinflammatory gene and restrain inflammation. PPARs could be one of the meeting background points with atherosclerosis/cardiovascular disease, diabetes and metabolic syndrome showing a modified proinflammatory statement such as it is described in periodontitis.</p></abstract><kwd-group><kwd>periodontitis</kwd><kwd>inflammasome</kwd><kwd>mitochondria</kwd><kwd>autophagy</kwd><kwd>atherosclerosis</kwd><kwd>diabetes</kwd><kwd>metabolic syndrome</kwd></kwd-group></article-meta></front><body><sec id="sec1-ijms-18-01438"><title>1. Introduction</title><p>Plaque-induced periodontal diseases are mixed infections which cause inflammation in the tissues around the teeth; this site is known as the periodontium and compromises all of its components. We divided it into two general categories based on whether illness to periodontium is reversible or not. So, respectively, we can differentiate between gingivitis and periodontitis [<xref rid="B1-ijms-18-01438" ref-type="bibr">1</xref>].</p><p>Gingivitis supposes the presence of gingival inflammation without loss of gingival attachment; the site affected is limited to the gingiva. On the other hand, periodontitis is an inflammatory disease of the periodontal tissues with a more complex pathogenic process. Main symptoms in periodontitis are an apical migration of gingival attachment, a progressive periodontal bone loss and the formation of a periodontal pocket. The endpoint in the progression of this process is the tooth loss. This disease does not compromise the life of the patient, but produces a decrease in their quality of life. Severe periodontitis may result in discomfort for the patient, tooth mobility, abscess formation, occasional pain, difficulty in chewing and finally, tooth loss [<xref rid="B2-ijms-18-01438" ref-type="bibr">2</xref>] (<xref ref-type="fig" rid="ijms-18-01438-f001">Figure 1</xref>).</p><p>Nowadays, periodontal diseases take real importance in our society on account of their high prevalence. The prevalence of gingivitis is over 80% with the peak being reached during puberty [<xref rid="B3-ijms-18-01438" ref-type="bibr">3</xref>]. Chronic periodontitis affects about 50% of the European population, and over 10% may suffer from an aggressive form, with this prevalence increasing up to 70&#8211;85% at 60&#8211;65 years of age [<xref rid="B4-ijms-18-01438" ref-type="bibr">4</xref>]. Also, it is expected that this prevalence data is maintaining during the next decade in Europe [<xref rid="B5-ijms-18-01438" ref-type="bibr">5</xref>]. Therefore, periodontal diseases are considered one of the most common diseases.</p><p>The key questions are the etiological and pathogenic processes involved, but many aspects are still unclear. Authors try to explain why in some patients, the disease produced by bacterial infection is limited to the gingiva and in others ones produces bone loss, and also the degree of bone resorption could be more or less severe, and even in aggressive periodontitis a lack of plaque and inflammation is described.</p><p>To explain it, researches have been focused on individual factors like the host response or microbial infection. Traditionally, the main cause of periodontal diseases is attributed to some bacterial species that colonize subgingival sites or pockets, which are the responsible for the inflammatory reaction. Nowadays, our treatment consists of reducing and eliminating the subgingival microorganisms. But, we have to recognize some significant limitations: we do not obtain success in all the patients, prevention is not feasible, we do not have any ways to identify the susceptible population, and a complete regeneration of periodontal tissues is presently impracticable. Besides, plaque is not essential in aggressive forms of periodontitis, and the control of the periodontal disease becomes more difficult [<xref rid="B6-ijms-18-01438" ref-type="bibr">6</xref>]. Certain microorganisms are related with the pathogenesis of periodontal disease, but the evidence does not support the invasion of a periodontal pathogen as a key step in this process [<xref rid="B7-ijms-18-01438" ref-type="bibr">7</xref>]. Therefore, periodontitis is produced by an imbalance among microbiota/dental biofilm and the inflammatory response that have to play a key role.</p><p>Inflammation is the main common backgrounds, with others systemic diseases such as atherosclerosis and atherosclerosis, diabetes and metabolic syndrome. These have been correlated with periodontitis in epidemiological studies. But, while periodontitis does not kill people, these others pathologies jeopardize the life of patients and are the main causes of death in our countries. All have a complex etiology, with a combination of non-modifiable risk factors (age or genetic), and modifiable risk factors: tobacco, alcohol, malnutrition, and chronic infection [<xref rid="B8-ijms-18-01438" ref-type="bibr">8</xref>].</p><p>Inflammation is a physiological response to stress which involves a multitude of processes. Firstly, it is necessary that innate immune system recognizes the aggression made by microorganisms, toxins and chemical compounds. These are identified as the pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns (DAMPs) that are recognized via the pattern recognition receptors (PRRs) [<xref rid="B9-ijms-18-01438" ref-type="bibr">9</xref>]. The cytoplasmic PAMPs and endogenous DAMPs activate PRRs and induce an intracellular signaling leading to the activation of inflammasome-driven inflammation [<xref rid="B10-ijms-18-01438" ref-type="bibr">10</xref>]. Inflammasomes are large multiprotein complexes localized in the cytoplasm of the cell; it is essential in initiating innate immune responses. They produce the maturation of pro-inflammatory cytokines and the activation of inflammatory cell death [<xref rid="B11-ijms-18-01438" ref-type="bibr">11</xref>]. Several inflammasomes are well-characterized for their role in recognition of PAMPs and DAMPs such as NLRP3 (nucleotide-binding leucine-rich repeat containing family, pyrin domain containing 3) [<xref rid="B12-ijms-18-01438" ref-type="bibr">12</xref>]. Inflammasome activity is central to appropriate host defense and protection from sepsis, but excessive inflammasome activation could be detrimental to health [<xref rid="B13-ijms-18-01438" ref-type="bibr">13</xref>].</p><p>Secondly, to maintain this inflammatory reaction, a sufficient supply of energy obtained from nutrients of the diet is necessary. But nowadays, humans have an excessive offer of nutrients that produce metabolic disorders. In the origin of these is a &#8220;proinflammatory&#8221; state produced by excessive caloric intake and over-nutrition and other innate conditions related with inflammation [<xref rid="B14-ijms-18-01438" ref-type="bibr">14</xref>]. These nutrients are metabolized via the Krebs cycle, fatty-acid oxidation and amino acid oxidation to obtain adenosine 5&#180;-triphosphate (ATP). This ATP is the fuel in cells of living organisms and the mitochondrion is the major source of ATP via cell respiration [<xref rid="B15-ijms-18-01438" ref-type="bibr">15</xref>]. During respiration, oxygen is used to oxidize molecules rich in carbon and hydrogen, and a reduction of oxygen to water. This reaction realizes free radicals and/or reactive oxygen species (ROS); both are capable of damage different substrates. The antioxidants are responsible for preventing the oxidative damage, but any defect in the respiratory chain, mitochondrial diseases and age could alter this balance and produce oxidative stress [<xref rid="B16-ijms-18-01438" ref-type="bibr">16</xref>]. Also, we cannot forget free radicals and ROS are essential in the physiological processes, but when an antioxidant system is unable to counteract their action efficiently, tissue and cell damage result [<xref rid="B17-ijms-18-01438" ref-type="bibr">17</xref>]. So, the role of oxidative stress is essential in the mechanisms of inflammatory condition [<xref rid="B14-ijms-18-01438" ref-type="bibr">14</xref>].</p><p>Finally, to maintain and control inflammation, cells need to function properly. The degradation of organelles and the elimination of invading pathogens are essential for the cell&#8217;s homeostasis. In this sense, one of the main catabolic pathways is autophagy. Autophagy allows for an appropriate response to stress and extrinsic or intrinsic insults [<xref rid="B18-ijms-18-01438" ref-type="bibr">18</xref>]. Impaired autophagy produce various pathologies, including cardiovascular disease and periodontitis [<xref rid="B19-ijms-18-01438" ref-type="bibr">19</xref>,<xref rid="B20-ijms-18-01438" ref-type="bibr">20</xref>], and is directly related to a regulatory role for ROS originated in mitochondria [<xref rid="B21-ijms-18-01438" ref-type="bibr">21</xref>]. When autophagy is blocked, this leads to activation the NLRP3 inflammasome, which explains the frequent association of mitochondrial damage with inflammatory diseases [<xref rid="B22-ijms-18-01438" ref-type="bibr">22</xref>]. Additionally, autophagy is regulated by the mammalian target of rapamycin (mTOR), which shuts off autophagy in the presence of growth factors and abundant nutrients [<xref rid="B23-ijms-18-01438" ref-type="bibr">23</xref>]. In vitro surveys suggest that periodontal pathogens can induce mTOR degradation in epithelial cells [<xref rid="B24-ijms-18-01438" ref-type="bibr">24</xref>]. Furthermore, the mTOR activates peroxisome proliferator-activated receptors (PPARs) [<xref rid="B25-ijms-18-01438" ref-type="bibr">25</xref>], which have been increasingly recognized as key players in the pathogeneses of metabolic diseases and primary metabolic regulators [<xref rid="B26-ijms-18-01438" ref-type="bibr">26</xref>]. In addition, PPARs are in direct relation with the NLRP3 inflammasome [<xref rid="B27-ijms-18-01438" ref-type="bibr">27</xref>].</p><p>It is well-known that periodontitis shares pathological features with the mentioned systemic pathologies [<xref rid="B7-ijms-18-01438" ref-type="bibr">7</xref>]. The evidence appears to indicate that the common link between periodontitis and systemic diseases seems to be inflammation [<xref rid="B9-ijms-18-01438" ref-type="bibr">9</xref>]. Although inflammation is a protective physiological response, it can sometimes lead to the destruction of tissue, starting a disease. There are a multitude of molecular routes related with inflammation which have been studied to explain the physiopathological processes taking place place in periodontitis. Routes related with inflammasomes and autophagy have been widely investigated [<xref rid="B9-ijms-18-01438" ref-type="bibr">9</xref>,<xref rid="B19-ijms-18-01438" ref-type="bibr">19</xref>]. Also, there is evidence for a decreased antioxidant capacity and mitochondrial dysfunction in patients with periodontitis [<xref rid="B28-ijms-18-01438" ref-type="bibr">28</xref>,<xref rid="B29-ijms-18-01438" ref-type="bibr">29</xref>]. In fact, animals studies have shown that antioxidant treatment with coenzyme Q is able to reduce the progression of alveolar bone destruction [<xref rid="B30-ijms-18-01438" ref-type="bibr">30</xref>].</p><p>Nowadays, the key questions in periodontitis remain unanswered. Why in some patients does the inflammatory response cause a pathology, and why not in another? With the recent knowledge we have gained, we have began to look for new keys in this process and to try to obtain an answer within this new family of receptors known as PPARs.</p></sec><sec id="sec2-ijms-18-01438"><title>2. Peroxisome Proliferator-Activated Receptors (PPARs) in Periodontitis as Inflammatory Disease</title><p>PPARs were originally identified in <italic>Xenopus</italic> frogs as receptors that induce the proliferation of peroxisomes in cells. They are a group of nuclear receptor proteins regulating the expression of genes. Three types of PPARs have been identified: &#945;, &#947;, &#946;/&#948;. PPAR&#945; is expressed in expressed in liver, kidney, heart, muscle, and adipose tissue. PPAR&#947; is expressed in all tissues. PPAR&#946;/&#948; is strongly expressed in brain, adipose tissue and skin. They are key players in the regulation of cellular differentiation, development, and metabolism (carbohydrate, lipid, protein), and tumor production [<xref rid="B31-ijms-18-01438" ref-type="bibr">31</xref>]. Basically, PPARs are considered as lipid sensors, that according to its availability leads to fatty acid metabolism or lipid storage. Also, PPARs play a major role in inflammation. For instance, they are involved in age-related inflammation, caloric restriction, and longevity [<xref rid="B32-ijms-18-01438" ref-type="bibr">32</xref>]. Activation of PPAR&#947; reduces the inflammation and can be activated by some non-steroidal anti-inflammatory and oral antidiabetic drugs. Many of PPAR&#947;&#8217;s established anti-inflammatory effects have been shown to occur through innate immune signaling, particularly in monocytes and macrophages, but new data is investigating the role of PPAR&#947; and its ligands (including thiazolidinediones, prostaglandins, and oleanolic acids) in the resolution of inflammation [<xref rid="B33-ijms-18-01438" ref-type="bibr">33</xref>]. Genetically modified mice showed that PPAR&#945;-impaired activity results in a modified inflammatory reaction, which causes a temporary delay in epidermal healing [<xref rid="B34-ijms-18-01438" ref-type="bibr">34</xref>]. The upregulation of PPAR&#946;/&#948; expression and endogenous agonist is triggered by tumor necrosis factor-&#945; (TNF-&#945;), a proinflammatory cytokine [<xref rid="B35-ijms-18-01438" ref-type="bibr">35</xref>]. The antiinflammatory role of PPAR&#946;/&#948; has been related to the utilization of agonists in different models of neurodegenerative diseases [<xref rid="B36-ijms-18-01438" ref-type="bibr">36</xref>]. In inflammatory bowel diseases, the activation of PPAR&#945; or PPAR&#947; has antiinflammatory effects in the intestine, decreasing the production of inflammatory markers and slowers the progression of colitis [<xref rid="B37-ijms-18-01438" ref-type="bibr">37</xref>]. PPAR&#945; is the molecular target of the fibrates class of drugs, such as fenofibrate, which act as agonistic ligands of PPAR&#945; [<xref rid="B38-ijms-18-01438" ref-type="bibr">38</xref>]. Also, PPAR&#945; ligands can inhibit the expression of various proinflammatory genes, such as interleukin (IL)-6, vascular cell adhesion molecule-1, platelet-activating factor (PAF) receptor and cyclooxygenase (COX)-2 generating prostaglandin E2 (PGE2) and thromboxane B2 (TxB2), in response to cytokine activation [<xref rid="B39-ijms-18-01438" ref-type="bibr">39</xref>].</p><p>On the whole, PPARs ligands activate PPARs to express their target genes. These agonists can be synthetic molecules, such as anti-hypertriglyceridemia drugs and insulin resistance, or fatty acids and eicosanoids. The first synthetic high-affinity ligand for PPAR&#946;/&#948; is the GW0742; it can modulate the inflammatory process and could limit the development of periodontitis. It has been demonstrated in rats to result in a substantial reduction of ligature-induced periodontitis, reducing plasma extravasation and the degree of bone resorption. Therefore, it could provide a promising approach for the treatment of periodontitis, reducing plasma extravasation and the bone resorption during periodontitis [<xref rid="B40-ijms-18-01438" ref-type="bibr">40</xref>].</p><p>At present, therapy with mesenchymal stem cells (MSC) is one of the most promising options to treat some diseases. Periodontal ligament stem cells have emerged as readily available therapeutic sources. They share core MSC properties such as colony formation and multipotential differentiation abilities, and may be ideal for repairing periodontal defects and achieving tooth regeneration with fewer drawbacks. Real-time PCR shows a highly elevated level of PPAR&#947; in these cells [<xref rid="B41-ijms-18-01438" ref-type="bibr">41</xref>]. One of the main bacteria involved in periodontitis is <italic>Porphyromonas gingivalis</italic>, and its lipopolysaccharide (LPS) induce the expression of inflammatory cytokines TNF-&#945;, IL-1&#946;, and IL-6 and chemokines IL-8 in human gingival fibroblasts (HGF) [<xref rid="B42-ijms-18-01438" ref-type="bibr">42</xref>]. The activation of PPAR&#947; could inhibit LPS-induced inflammatory response [<xref rid="B43-ijms-18-01438" ref-type="bibr">43</xref>] (<xref ref-type="fig" rid="ijms-18-01438-f002">Figure 2</xref>). A major metabolite of anthocyanins, the protocatechnic acid, inhibit LPS-induced inflammation, suppressed IL-6 and IL-8 production in LPS-stimulated HGF and can be reversed by the PPAR&#947; antagonist GW9662 [<xref rid="B44-ijms-18-01438" ref-type="bibr">44</xref>]. The evidence that rosiglitazone (RGZ), a PPAR&#947; agonist, reduces acute and chronic inflammation has been tested in a rat model of periodontitis. It demonstrated a reduction in the development of periodontitis, the presence in the mucogingival tissues with polymorphonuclear cells, the degree of nitrotyrosine formation and the level of injury in mucogingival tissues. All these findings support an attenuation of the damage produced in experimental periodontitis [<xref rid="B45-ijms-18-01438" ref-type="bibr">45</xref>]. The interaction between PPAR&#947; gene polymorphism with periodontal disease has been studied in some papers without a clear conclusion. The association of five polymorphisms (rs10865710, rs2067819, rs3892175, rs1801282, rs3856806) within the PPARG gene with chronic periodontitis was studied in a group of patients aged from eight to 85 years-old. The results show that none of the haplotypes was significantly different between the periodontitis and healthy controls. Therefore, it could not demonstrate a significant association between PPARG gene variants and chronic periodontitis [<xref rid="B46-ijms-18-01438" ref-type="bibr">46</xref>]. In a group of pregnant women (the average age of the subjects being approximately 31 years-old), it could not be demonstrated an association between the PPAR&#947; Pro12Ala polymorphism and the presence of periodontitis because they did not reach statistical significance [<xref rid="B47-ijms-18-01438" ref-type="bibr">47</xref>]. Later the same group of authors showed a significant association with periodontal disease in obese elderly females, indicating a gene&#8211;gene or gene&#8211;environmental interaction among periodontal disease and each gene polymorphism [<xref rid="B48-ijms-18-01438" ref-type="bibr">48</xref>]. Another study made in a group of postmenopausal women with slight periodontitis do not demonstrate any independent associations between the PPAR&#947; Pro12Ala polymorphism and any of the periodontal clinical parameters [<xref rid="B49-ijms-18-01438" ref-type="bibr">49</xref>].</p></sec><sec id="sec3-ijms-18-01438"><title>3. PPARs in Periodontitis as Bone Disease</title><p>The balance of bone metabolism is supported by osteoclast-induced bone resorption and osteoblast-induced bone formation. Osteoblastic lineage cells and activated T lymphocytes produce a receptor activator of nuclear factor (NF-&#954;B) ligand (RANKL). It is the essential factor for osteoclast formation, fusion, activation, and survival, resulting in bone resorption and bone loss. RANKL has a specific receptor located on osteoclast and dendritic cells: RANK. The activation of RANK promotes the signaling cascade including stimulation of the c-jun, NF-&#954;B, and protein serine/threonine kinase (PKB/Akt) pathways. The effects of RANKL are counteracted by osteoprotegerin (OPG) which acts as a soluble neutralizing receptor. The regulation of RANKL and OPG are mediated by cytokines (tumor necrosis factor &#945;, interleukins 1, 4, 6, 11, and 17), various hormones (glucocorticoids, vitamin D, estrogen), and several mesenchymal transcription factors (such as Cbfa-1, peroxisome proliferator-activated receptor &#947;, and Indian hedgehog).</p><p>Stimulation of PPAR&#947; induces the development of mesenchymal stem cells into adipocytes instead of osteoblasts and results in the decrease of the number of osteoblasts and bone mineral density (BMD). PPAR&#947; gene polymorphisms have been reported to be associated with bone loss and osteoporosis [<xref rid="B51-ijms-18-01438" ref-type="bibr">51</xref>]. A study showed that PPAR&#947; also functions as an essential modulator of osteoclast differentiation. Mice with PPAR&#947;-deficiency in their hematopoietic lineage cells are osteopetrotic as a result of impaired c-Fos expression. These data suggest that PPAR&#947; acts as an important regulator of c-os expression [<xref rid="B52-ijms-18-01438" ref-type="bibr">52</xref>]. Another study demonstrates that the activation of liver X receptor (LXR) attenuated the PPAR&#947; agonist-induced c-Fos expression, and the ectopic expression of LXR suppressed PPAR&#947;-induced Activator protein 1 (AP-1) promoter activity. LXR can be identified as a negative regulator of PPAR-mediated induction of c-Fos and transactivation of AP-1 in the context of osteoclast development. The authors propose that LXR agonists may be of value in the treatment of bone-erosive diseases characterized by increased osteoclast number [<xref rid="B53-ijms-18-01438" ref-type="bibr">53</xref>].</p><p>Mechanical loading is essential in the maintenance of bone mass and structures around the teeth and bone physiology. Some papers indicate that the mechanical loading of osteoblasts produces the expression of transcription factor PPAR&#947;-1 mRNA. The coordinated synthesis of &#916;<sup>12</sup>PGJ<sub>2</sub>, a natural ligand for PPAR&#947;-1, with the increased expression of PPAR&#947;-1, point out that the biomechanical transduction pathways that initially involve the activation of cyclooxygenases may also require the activation of the &#916;<sup>12</sup>PGJ<sub>2</sub>&#8211;PPAR pathway [<xref rid="B54-ijms-18-01438" ref-type="bibr">54</xref>]. These data also suggest that prostaglandin (PGD2) biosynthesis induced in bone cells by mechanical stress may be one of the major inducers of osteogenesis. The same group of authors investigated the molecular events produced in osteogenesis secondary to mechanical loading and &#916;<sup>12</sup>PGJ<sub>2</sub>, namely the induction of bone morphogenetic proteins and peroxisome proliferator-activated receptor &#947;-1, a nuclear receptor for &#916;<sup>12</sup>PGJ<sub>2</sub>. Mechanical strain increased the mRNA expression of peroxisome proliferator-activated receptor &#947;-1. In stretched cells, bone peroxisome proliferator-activated receptor &#947;-1 expression was blocked by cyclooxygenase inhibitors, but improved by exogenous &#916;<sup>12</sup>PGJ<sub>2.</sub> These data suggest that the &#916;<sup>12</sup>PGJ<sub>2</sub>/peroxisome proliferator-activated receptor &#947;-1 is essential in osteogenesis [<xref rid="B55-ijms-18-01438" ref-type="bibr">55</xref>]. The effect of &#916;<sup>12</sup>PGJ<sub>2</sub> on periodontitis inhibited the production of interleukin-6 (IL-6) in osteoblast-like cells MC3T3E-1 incubated with LPS. Data showed that it is an effective inhibitor of the LPS-stimulated IL-6 production, in a dose-dependent manner, through the blockade of NF-&#954;B and the Akt pathway. These data suggest a possible mechanism responsible for its anti-inflammatory action and the use as a therapeutic drug for treating LPS-stimulated periodontal diseases [<xref rid="B56-ijms-18-01438" ref-type="bibr">56</xref>].</p><p>A relationship between osteoporosis and periodontal conditions has been studied. Systemic bone density and oral infection, analyzed in the presence of a periodontal bacteria such as <italic>Tannerella forsythensis</italic>, was found to modify oral bone loss in post-menopausal women aged &lt;70 years [<xref rid="B57-ijms-18-01438" ref-type="bibr">57</xref>]. In a group of 400 postmenopausal women, osteoporosis was significantly associated with severe alveolar crestal bone loss and the prevalence of periodontitis cases [<xref rid="B58-ijms-18-01438" ref-type="bibr">58</xref>]. Another paper showed data from 90 women aged 45&#8211;70 years; the osteoporotic women presented severe periodontitis with greater gingival inflammation, greater clinical attachment level and greater gingival recession than the women with normal BMD [<xref rid="B59-ijms-18-01438" ref-type="bibr">59</xref>]. A group of 179 male and female patients were divided into an osteopenia, and a non-osteopenia group and a follow-up clinical surveys were done by measuring periodontal conditions after 3 years. BMD was related to the number of progressive sites which had additional attachment loss during the observational period [<xref rid="B60-ijms-18-01438" ref-type="bibr">60</xref>].</p><p>Pathogenic bone resorption occurring in periodontal disease is known to be produced by inflammation, PPAR&#947; activation can downregulate the bone resorption mediated by RANKL-dependent osteoclastogenesis. RGZ, a high-affinity synthetic agonist for PPAR&#947;, influences the bone resorption induced in rats by experimental periodontitis caused by ligature placement around the tooth. Histological and immunohistochemical analysis showed that the treatment with RGZ decreased bone resorption, alongside reduced RANKL expression, in contrast to those animals treated with empty vehicles. Also, along with these results obtained from in vivo experiments, RGZ also suppressed in vitro osteoclast differentiation in the presence of RANKL in mouse monocyte/macrophage (MOCP-5) osteoclast precursor cells, and the downregulation of the expression of RANKL-induced TRAP mRNA. So, RGZ might suppress the bone resorption by inhibiting RANKL-mediated osteoclastogenesis obtained during experimental periodontitis in rats [<xref rid="B61-ijms-18-01438" ref-type="bibr">61</xref>].</p><p>A study investigated the potential associations between the PPAR&#947; Pro12Ala polymorphism, periodontitis and bone mineral density (BMD) in 674 women between the ages of 55 and 74 years-old. The association between BMD or periodontitis and PPARG Pro12Ala polymorphism was not independent. The common point could be in the modulator role of the polymorphism in this relationship [<xref rid="B62-ijms-18-01438" ref-type="bibr">62</xref>].</p><p>In dentistry, the treatment with implants involved the bone integration of the titanium surface without any inflammation. Some papers have been proposed to deliver antiinflammatory molecules PPAR&#947; on titanium surfaces using chitosan gold nanoparticles (Ch-GNPs). They evaluated the protein levels of TNF-&#945; and IL-1&#946; in RAW 264.7 cells. Expression of these cytokines was not observed in cells cultured on Ch-GNPs/PPAR&#947;-coated titanium surfaces. But, upregulation of pro-inflammatory cytokines was detected on non-coated and Ch-GNPs/LacZ-coated titanium surfaces. These data suggested that the Ch-GNPs/PPAR&#947; coated titanium surfaces could carry the anti-inflammatory gene and inhibit inflammation [<xref rid="B63-ijms-18-01438" ref-type="bibr">63</xref>].</p></sec><sec id="sec4-ijms-18-01438"><title>4. PPARs in Periodontitis and Its Related Systemic Diseases</title><p>We have shown that periodontitis is related to some systemic diseases such as cardiovascular disease produced by atherosclerosis, diabetes mellitus, and metabolic syndrome. The pathophysiology of these diseases share a common background of low-grade modified inflammation. Periodontitis results from an imbalance of the bacteria and the host inflammatory response that produce an irreversible alveolar bone resorption, leading to tooth loss. Nowadays, the key question is why in some patients, the inflammation is limited to gingivitis as a reversible disease, and in others produces periodontitis with an irreversible alveolar bone loss. One of the possible mechanisms is an impaired inflammatory response. We have proposed that the interrelationship could lie at a cellular level, namely oxidative stress and mitochondrial dysfunction, as a meeting background among such chronic diseases and periodontitis [<xref rid="B64-ijms-18-01438" ref-type="bibr">64</xref>]. Also, all the periodontitis-related systemic diseases show in its pathogenic mechanism an altered inflammation associated with an excessive caloric intake and increased or inadequate free fatty acid intakes [<xref rid="B65-ijms-18-01438" ref-type="bibr">65</xref>]. Even the origins of susceptibility for these diseases in the adult can be identified to the early life, early-life nutrition plays an essential role in placental and fetal growth, organogenesis, and development [<xref rid="B66-ijms-18-01438" ref-type="bibr">66</xref>]. PPARs contribute to the plasticity of the placenta and are under epigenetic control; it has been proposed there is a relationship between environmental factors, such as maternal nutrition, and the epigenetic regulation of PPRs [<xref rid="B67-ijms-18-01438" ref-type="bibr">67</xref>]. Glucose and related sugars, lipids, and amino acids are essential nutrients. The control of the above environmental nutrient levels is essential for life; it is controlled by nutrient-sensing mechanisms and pathways. One of them is PPARs; they are nutrient-sensing nuclear receptors with integrators activity in metabolic responses [<xref rid="B68-ijms-18-01438" ref-type="bibr">68</xref>].</p><p>Metabolic syndrome is defined as the combination of multiple metabolic disorders, including obesity, dyslipidemia, glucose intolerance, inflammation, and hypertension. Low-grade inflammation is a common background between insulin resistance, obesity and type-2 diabetes [<xref rid="B65-ijms-18-01438" ref-type="bibr">65</xref>]. In recent years, some studies showed that PPARs could improve several of the metabolic abnormalities associated with the metabolic syndrome [<xref rid="B69-ijms-18-01438" ref-type="bibr">69</xref>].</p><p>Specific genetic polymorphisms have been associated with a susceptibility to obesity. Expression of these susceptibility genes can be modified by epigenetic and environmental factors. Diet and nutritional status can affect the transcription factors and microRNAs (miRNAs) regulatory systems. Evidence from in vitro studies and from human studies has identified specific miRNAs associated with obesity. miRNAs are small, non-coding RNA molecules that bind and form complexes with mRNA species, namely to the 3&#8217;UTR of the mRNA [<xref rid="B70-ijms-18-01438" ref-type="bibr">70</xref>]. miRNAs regulate adipocyte development and lipid metabolism. Expression of miR-27 suppresses the translation of peroxisome proliferator-activated receptor-&#947; (PPAR&#947;) and is an essential early regulator of adipogenesis [<xref rid="B71-ijms-18-01438" ref-type="bibr">71</xref>]. miR-143 expression is upregulated 3.3-fold in obese mice, and increases the adipocyte differentiation markers PPAR&#947; and the adipocyte fatty-acid-binding protein [<xref rid="B72-ijms-18-01438" ref-type="bibr">72</xref>]. PPAR&#947; also regulates adipogenesis, and its polymorphisms have been suggested to be a risk for obesity. Body mass index (BMI) has been associated with Pro12Ala polymorphism [<xref rid="B73-ijms-18-01438" ref-type="bibr">73</xref>]. Also, it was studied whether the Pro12Ala polymorphism of peroxisome proliferator-activated receptor &#947; (PPAR&#947;) is related to insulin resistance, obesity, and weight loss and the potential interactions between fat intake and PPAR&#947; polymorphism was explored. Data showed a protective role for the Ala12 allele against insulin resistance, and the interaction between dietary monounsaturated fatty acids (MUFA) and PPAR&#947;2 for BMI [<xref rid="B74-ijms-18-01438" ref-type="bibr">74</xref>]. PPAR&#947; increased the plasma adiponectin concentration and is suggested as a therapeutic tool through the dietary regulation by derivatives of its active compounds, such as vitamins, polyunsaturated fatty acids (PUFA) or carotenoids [<xref rid="B75-ijms-18-01438" ref-type="bibr">75</xref>].</p><p>The relationship between cardiovascular disease and PPAR has been reported. PPAR&#946;/&#948; ligands and the overexpression of this nuclear receptor inhibits myocardial inflammatory responses, such as the lipopolysaccharide-mediated production of TNF-&#945;. This had positive effects on animals that had undergone an ischemia/reperfusion injury or cardiac hypertrophy [<xref rid="B76-ijms-18-01438" ref-type="bibr">76</xref>]. PPAR&#946;/&#948; ligands are capable of improving cardiac function, and can even enhance some cardiac diseases such as heart failure, oxidative damage, hypertrophy, ischemia&#8211;reperfusion injury, lipotoxic cardiac dysfunction and lipid-induced cardiac inflammation [<xref rid="B77-ijms-18-01438" ref-type="bibr">77</xref>].</p><p>The pathophysiology of diabetes includes an important inflammatory aspect. PPAR&#945; is essential in the dysregulation of inflammation. PPAR&#945; protein level was examined by immunohistochemistry in type-2 diabetic Goto-Kakizaki rats with induced periodontitis. The results showed the number of gingival fibroblast with PPAR-&#945; protein was low at baseline and then in both, normoglycemic and diabetic rats with ligature-induced periodontitis. When the ligature was removed and the periodontitis solved, the normoglycemic rats presented a threefold increase in the relative expression of PPAR&#945;. On the contrary, no change was observed in the diabetic animals. However, diabetic rats treated with TNF-inhibitor, showed a significant increase, so that the diabetic rats with TNF-inhibitor function similarly to the normal animals. Thus, PPAR&#945; could participate in the resolution of periodontitis through its antiinflammatory properties, but under diabetic conditions, its upregulation is restrained [<xref rid="B78-ijms-18-01438" ref-type="bibr">78</xref>].</p><p>The role of monocytes and macrophages in diabetic periodontal diseases has been investigated; the results indicated that monocytes and macrophages are important players in periodontal tissue inflammation and destruction in diabetic patients. Monocytes isolated from diabetic patients produce a greater amount of TNF-&#945; and interleukin-1&#946; in vitro than do nondiabetic controls [<xref rid="B79-ijms-18-01438" ref-type="bibr">79</xref>]. A high glucose content markedly increased lipopolysaccharide-induced inflammatory cytokine and inducible nitric oxide synthase (iNOS) expression in U937 macrophages. These data indicated that hyperglycemia in diabetic patients may boost the inflammatory response leading to increased cytokine release. An antidyslipidemic drug, fenofibrate, increased lipopolysaccharide, induced TNF-&#945; secretion and an antidiabetic drug, pioglitazone; increased lipopolysaccharide-induced TNF-&#945;, interleukin-1&#946;, and interleukin-6 secretion. But, pioglitazone and fenofibrate do not inhibit the stimulatory effect of high glucose and lipopolysaccharide on the secretion of pro-inflammatory cytokines effectively, but only if it suppressed by statin [<xref rid="B80-ijms-18-01438" ref-type="bibr">80</xref>].</p></sec><sec id="sec5-ijms-18-01438"><title>5. Conclusions</title><p>In the complex process involving inflammatory diseases such as periodontal disease, cardiovascular disease, diabetes and metabolic syndrome, PPARs could play an important role and give new clues to a better therapeutic approach. PPARs are the molecular targets of a number of marketed drugs. We should use those to prevent or treat periodontal diseases. This is our new challenge.</p></sec></body><back><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">PAMPs</td><td align="left" valign="top" rowspan="1" colspan="1">Pathogen-Associated Molecular Patterns</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DAMPs</td><td align="left" valign="top" rowspan="1" colspan="1">Danger-Associated Molecular Patterns</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PRRs</td><td align="left" valign="top" rowspan="1" colspan="1">Pattern Recognition Receptors</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NLRP3</td><td align="left" valign="top" rowspan="1" colspan="1">Nod Like Receptors Family, Pyrin Domain Containing 3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ATP</td><td align="left" valign="top" rowspan="1" colspan="1">Adenosine 5&#180;-Triphosphate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ROS</td><td align="left" valign="top" rowspan="1" colspan="1">Reactive Oxygen Species</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">mTOR</td><td align="left" valign="top" rowspan="1" colspan="1">Mammalian Target of Rapamycin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL</td><td align="left" valign="top" rowspan="1" colspan="1">Interleukin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">COX</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclooxygenase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MSC</td><td align="left" valign="top" rowspan="1" colspan="1">Mesenchymal Stem Cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HGF</td><td align="left" valign="top" rowspan="1" colspan="1">Human Gingival Fibroblasts</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RGZ</td><td align="left" valign="top" rowspan="1" colspan="1">Rosiglitazone</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RANKL</td><td align="left" valign="top" rowspan="1" colspan="1">Receptor Activator for Nuclear Factor &#954; B Ligand</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NF-&#954;B</td><td align="left" valign="top" rowspan="1" colspan="1">nuclear factor kappa-light-chain-enhancer of activated B cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">OPG</td><td align="left" valign="top" rowspan="1" colspan="1">Osteoprotegerin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMD</td><td align="left" valign="top" rowspan="1" colspan="1">Bone Mineral Density</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ch-GNPs</td><td align="left" valign="top" rowspan="1" colspan="1">Chitosan Gold Nanoparticles</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">miRNAs</td><td align="left" valign="top" rowspan="1" colspan="1">MicroRNAs</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI</td><td align="left" valign="top" rowspan="1" colspan="1">Body Mass Index</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MUFA</td><td align="left" valign="top" rowspan="1" colspan="1">Monounsaturated Fatty Acids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PUFA</td><td align="left" valign="top" rowspan="1" colspan="1">Polyunsaturated Fatty Acids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TNF</td><td align="left" valign="top" rowspan="1" colspan="1">Tumor Necrosis Factor</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-ijms-18-01438"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armitage</surname><given-names>G.C.</given-names></name></person-group><article-title>Diagnosis of periodontal diseases</article-title><source>J. Periodontol.</source><year>2003</year><volume>74</volume><fpage>1237</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1902/annals.1996.1.1.37</pub-id><?supplied-pmid 14514240?><pub-id pub-id-type="pmid">14514240</pub-id></element-citation></ref><ref id="B2-ijms-18-01438"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buset</surname><given-names>S.L.</given-names></name><name><surname>Walter</surname><given-names>C.</given-names></name><name><surname>Friedmann</surname><given-names>A.</given-names></name><name><surname>Weiger</surname><given-names>R.</given-names></name><name><surname>Borgnakke</surname><given-names>W.S.</given-names></name><name><surname>Zitzmann</surname><given-names>N.U.</given-names></name></person-group><article-title>Are periodontal diseases really silent? A systematic review of their effect on quality of life</article-title><source>J. Clin. Periodontol.</source><year>2016</year><volume>43</volume><fpage>333</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1111/jcpe.12517</pub-id><?supplied-pmid 26810308?><pub-id pub-id-type="pmid">26810308</pub-id></element-citation></ref><ref id="B3-ijms-18-01438"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>W.M.M.</given-names></name><name><surname>Papapanou</surname><given-names>P.N.</given-names></name></person-group><article-title>Epidemiology of periodontal disease in children and adolescents</article-title><source>Periodontol. 2000</source><year>2001</year><volume>26</volume><fpage>16</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0757.2001.2260102.x</pub-id><?supplied-pmid 11452904?><pub-id pub-id-type="pmid">11452904</pub-id></element-citation></ref><ref id="B4-ijms-18-01438"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#246;nig</surname><given-names>J.</given-names></name><name><surname>Holtfreter</surname><given-names>B.</given-names></name><name><surname>Kocher</surname><given-names>T.</given-names></name></person-group><article-title>Periodontal health in Europe: Future trends based on treatment needs and the provision of periodontal services&#8212;Position paper 1</article-title><source>Eur. J. Dent. Educ.</source><year>2010</year><volume>14</volume><fpage>4</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0579.2010.00620.x</pub-id><?supplied-pmid 20415972?><pub-id pub-id-type="pmid">20415972</pub-id></element-citation></ref><ref id="B5-ijms-18-01438"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madianos</surname><given-names>P.</given-names></name><name><surname>Papaioannou</surname><given-names>W.</given-names></name><name><surname>Herrera</surname><given-names>D.</given-names></name><name><surname>Sanz</surname><given-names>M.</given-names></name><name><surname>Baeumer</surname><given-names>A.</given-names></name><name><surname>Bogren</surname><given-names>A.</given-names></name><name><surname>Bouchard</surname><given-names>P.</given-names></name><name><surname>Chomyszyn-Gajewska</surname><given-names>M.</given-names></name><name><surname>Demirel</surname><given-names>K.</given-names></name><name><surname>Gaspersic</surname><given-names>R.</given-names></name><etal/></person-group><article-title>EFP Delphi study on the trends in periodontology and periodontics in Europe for the year 2025</article-title><source>J. Clin. Periodontol.</source><year>2016</year><volume>43</volume><fpage>472</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1111/jcpe.12551</pub-id><?supplied-pmid 26996547?><pub-id pub-id-type="pmid">26996547</pub-id></element-citation></ref><ref id="B6-ijms-18-01438"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armitage</surname><given-names>G.C.</given-names></name></person-group><article-title>Periodontal diagnoses and classification of periodontal diseases</article-title><source>Periodontol. 2000</source><year>2004</year><volume>34</volume><fpage>9</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1046/j.0906-6713.2002.003421.x</pub-id><?supplied-pmid 14717852?><pub-id pub-id-type="pmid">14717852</pub-id></element-citation></ref><ref id="B7-ijms-18-01438"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendes</surname><given-names>L.</given-names></name><name><surname>Azevedo</surname><given-names>N.F.</given-names></name><name><surname>Felino</surname><given-names>A.</given-names></name><name><surname>Pinto</surname><given-names>M.G.</given-names></name></person-group><article-title>Relationship between invasion of the periodontium by periodontal pathogens and periodontal disease: A systematic review</article-title><source>Virulence</source><year>2015</year><volume>6</volume><fpage>208</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.4161/21505594.2014.984566</pub-id><?supplied-pmid 25654367?><pub-id pub-id-type="pmid">25654367</pub-id></element-citation></ref><ref id="B8-ijms-18-01438"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferretti</surname><given-names>F.</given-names></name></person-group><article-title>Unhealthy Behaviours: An International Comparison</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0141834</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0141834</pub-id><?supplied-pmid 26512717?><pub-id pub-id-type="pmid">26512717</pub-id></element-citation></ref><ref id="B9-ijms-18-01438"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoni</surname><given-names>G.</given-names></name><name><surname>Cardinali</surname><given-names>C.</given-names></name><name><surname>Morelli</surname><given-names>M.B.</given-names></name><name><surname>Santoni</surname><given-names>M.</given-names></name><name><surname>Nabissi</surname><given-names>M.</given-names></name><name><surname>Amantini</surname><given-names>C.</given-names></name></person-group><article-title>Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons</article-title><source>J. Neuroinflamm.</source><year>2015</year><volume>12</volume><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/s12974-015-0239-2</pub-id><?supplied-pmid 25644504?><pub-id pub-id-type="pmid">25644504</pub-id></element-citation></ref><ref id="B10-ijms-18-01438"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroder</surname><given-names>K.</given-names></name><name><surname>Tschopp</surname><given-names>J.</given-names></name></person-group><article-title>The inflammasomes</article-title><source>Cell</source><year>2010</year><volume>140</volume><fpage>821</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.040</pub-id><?supplied-pmid 20303873?><pub-id pub-id-type="pmid">20303873</pub-id></element-citation></ref><ref id="B11-ijms-18-01438"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedra</surname><given-names>J.H.F.</given-names></name><name><surname>Cassel</surname><given-names>S.L.</given-names></name><name><surname>Sutterwala</surname><given-names>F.S.</given-names></name></person-group><article-title>Sensing pathogens and danger signals by the inflammasome</article-title><source>Curr. Opin. Immunol.</source><year>2009</year><volume>21</volume><fpage>10</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2009.01.006</pub-id><?supplied-pmid 19223160?><pub-id pub-id-type="pmid">19223160</pub-id></element-citation></ref><ref id="B12-ijms-18-01438"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>I.</given-names></name><name><surname>Yilmaz</surname><given-names>&#214;.</given-names></name></person-group><article-title>Modulation of inflammasome activity by <italic>Porphyromonas gingivalis</italic> in periodontitis and associated systemic diseases</article-title><source>J. Oral Microbiol.</source><year>2016</year><volume>8</volume><fpage>30385</fpage><pub-id pub-id-type="doi">10.3402/jom.v8.30385</pub-id><?supplied-pmid 26850450?><pub-id pub-id-type="pmid">26850450</pub-id></element-citation></ref><ref id="B13-ijms-18-01438"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dagenais</surname><given-names>M.</given-names></name><name><surname>Skeldon</surname><given-names>A.</given-names></name><name><surname>Saleh</surname><given-names>M.</given-names></name></person-group><article-title>The inflammasome: In memory of Dr. Jurg Tschopp</article-title><source>Cell Death Differ.</source><year>2012</year><volume>19</volume><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/cdd.2011.159</pub-id><?supplied-pmid 22075986?><pub-id pub-id-type="pmid">22075986</pub-id></element-citation></ref><ref id="B14-ijms-18-01438"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varela-L&#243;pez</surname><given-names>A.</given-names></name><name><surname>Quiles</surname><given-names>J.L.</given-names></name><name><surname>Cordero</surname><given-names>M.</given-names></name><name><surname>Giampieri</surname><given-names>F.</given-names></name><name><surname>Bull&#243;n</surname><given-names>P.</given-names></name></person-group><article-title>Oxidative stress and dietary fat type in relation to periodontal disease</article-title><source>Antioxidants</source><year>2015</year><volume>4</volume><fpage>322</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.3390/antiox4020322</pub-id><?supplied-pmid 26783708?><pub-id pub-id-type="pmid">26783708</pub-id></element-citation></ref><ref id="B15-ijms-18-01438"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sies</surname><given-names>H.</given-names></name></person-group><article-title>Biochemistry of oxidative stress</article-title><source>Angew. Chem. Int. Ed. Engl.</source><year>1986</year><volume>25</volume><fpage>1058</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1002/anie.198610581</pub-id></element-citation></ref><ref id="B16-ijms-18-01438"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valko</surname><given-names>M.</given-names></name><name><surname>Leibfritz</surname><given-names>D.</given-names></name><name><surname>Moncol</surname><given-names>J.</given-names></name><name><surname>Cronin</surname><given-names>M.T.D.</given-names></name><name><surname>Mazur</surname><given-names>M.</given-names></name><name><surname>Telser</surname><given-names>J.</given-names></name></person-group><article-title>Free radicals and antioxidants in normal physiological functions and human disease</article-title><source>Int. J. Biochem. Cell Biol.</source><year>2007</year><volume>39</volume><fpage>44</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2006.07.001</pub-id><?supplied-pmid 16978905?><pub-id pub-id-type="pmid">16978905</pub-id></element-citation></ref><ref id="B17-ijms-18-01438"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battino</surname><given-names>M.</given-names></name><name><surname>Bullon</surname><given-names>P.</given-names></name><name><surname>Wilson</surname><given-names>M.</given-names></name><name><surname>Newman</surname><given-names>H.</given-names></name></person-group><article-title>Oxidative Injury and inflammatory periodontal diseases&#8239;: The challenge of anti-oxidants to free radicals and reactive oxygen species</article-title><source>Crit. Rev. Oral Biol. Med.</source><year>1999</year><volume>10</volume><fpage>458</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1177/10454411990100040301</pub-id><?supplied-pmid 10634583?><pub-id pub-id-type="pmid">10634583</pub-id></element-citation></ref><ref id="B18-ijms-18-01438"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroemer</surname><given-names>G.</given-names></name><name><surname>Mari&#241;o</surname><given-names>G.</given-names></name><name><surname>Levine</surname><given-names>B.</given-names></name></person-group><article-title>Autophagy and the integrated stress response</article-title><source>Mol. Cell</source><year>2010</year><volume>40</volume><fpage>280</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.09.023</pub-id><?supplied-pmid 20965422?><pub-id pub-id-type="pmid">20965422</pub-id></element-citation></ref><ref id="B19-ijms-18-01438"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>B.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group><article-title>Autophagy in the pathogenesis of disease</article-title><source>Cell</source><year>2008</year><volume>132</volume><fpage>27</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.12.018</pub-id><?supplied-pmid 18191218?><pub-id pub-id-type="pmid">18191218</pub-id></element-citation></ref><ref id="B20-ijms-18-01438"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullon</surname><given-names>P.</given-names></name><name><surname>Cordero</surname><given-names>M.D.</given-names></name><name><surname>Quiles</surname><given-names>J.L.</given-names></name><name><surname>Ramirez-Tortosa</surname><given-names>M.D.C.</given-names></name><name><surname>Gonzalez-Alonso</surname><given-names>A.</given-names></name><name><surname>Alfonsi</surname><given-names>S.</given-names></name><name><surname>Garc&#237;a-Mar&#237;n</surname><given-names>R.</given-names></name><name><surname>de Miguel</surname><given-names>M.</given-names></name><name><surname>Battino</surname><given-names>M.</given-names></name></person-group><article-title>Autophagy in periodontitis patients and gingival fibroblasts: Unraveling the link between chronic diseases and inflammation</article-title><source>BMC Med.</source><year>2012</year><volume>10</volume><elocation-id>122</elocation-id><pub-id pub-id-type="doi">10.1186/1741-7015-10-122</pub-id><?supplied-pmid 23075094?><pub-id pub-id-type="pmid">23075094</pub-id></element-citation></ref><ref id="B21-ijms-18-01438"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherz-Shouval</surname><given-names>R.</given-names></name><name><surname>Elazar</surname><given-names>Z.</given-names></name></person-group><article-title>ROS, mitochondria and the regulation of autophagy</article-title><source>Trends Cell Biol.</source><year>2007</year><volume>17</volume><fpage>422</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2007.07.009</pub-id><?supplied-pmid 17804237?><pub-id pub-id-type="pmid">17804237</pub-id></element-citation></ref><ref id="B22-ijms-18-01438"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>R.</given-names></name><name><surname>Yazdi</surname><given-names>A.S.</given-names></name><name><surname>Menu</surname><given-names>P.</given-names></name><name><surname>Tschopp</surname><given-names>J.</given-names></name></person-group><article-title>A role for mitochondria in NLRP3 inflammasome activation</article-title><source>Nature</source><year>2011</year><volume>469</volume><fpage>221</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1038/nature09663</pub-id><?supplied-pmid 21124315?><pub-id pub-id-type="pmid">21124315</pub-id></element-citation></ref><ref id="B23-ijms-18-01438"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>C.H.</given-names></name><name><surname>Ro</surname><given-names>S.-H.</given-names></name><name><surname>Cao</surname><given-names>J.</given-names></name><name><surname>Otto</surname><given-names>N.M.</given-names></name><name><surname>Kim</surname><given-names>D.-H.</given-names></name></person-group><article-title>mTOR regulation of autophagy</article-title><source>FEBS Lett.</source><year>2010</year><volume>584</volume><fpage>1287</fpage><lpage>1295</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2010.01.017</pub-id><?supplied-pmid 20083114?><pub-id pub-id-type="pmid">20083114</pub-id></element-citation></ref><ref id="B24-ijms-18-01438"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stafford</surname><given-names>P.</given-names></name><name><surname>Higham</surname><given-names>J.</given-names></name><name><surname>Pinnock</surname><given-names>A.</given-names></name><name><surname>Murdoch</surname><given-names>C.</given-names></name><name><surname>Douglas</surname><given-names>C.W.I.</given-names></name><name><surname>Stafford</surname><given-names>G.P.</given-names></name><name><surname>Lambert</surname><given-names>D.W.</given-names></name></person-group><article-title>Gingipain-dependent degradation of mammalian target of rapamycin pathway proteins by the periodontal pathogen <italic>Porphyromonas gingivalis</italic> during invasion</article-title><source>Mol. Oral Microbiol.</source><year>2013</year><volume>28</volume><fpage>366</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1111/omi.12030</pub-id><?supplied-pmid 23714361?><pub-id pub-id-type="pmid">23714361</pub-id></element-citation></ref><ref id="B25-ijms-18-01438"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanchard</surname><given-names>P.-G.</given-names></name><name><surname>Festuccia</surname><given-names>W.T.</given-names></name><name><surname>Houde</surname><given-names>V.P.</given-names></name><name><surname>St-Pierre</surname><given-names>P.</given-names></name><name><surname>Br&#251;l&#233;</surname><given-names>S.</given-names></name><name><surname>Turcotte</surname><given-names>V.</given-names></name><name><surname>C&#244;t&#233;</surname><given-names>M.</given-names></name><name><surname>Bellmann</surname><given-names>K.</given-names></name><name><surname>Marette</surname><given-names>A.</given-names></name><name><surname>Deshaies</surname><given-names>Y.</given-names></name></person-group><article-title>Major involvement of mTOR in the PPAR&#947;-induced stimulation of adipose tissue lipid uptake and fat accretion</article-title><source>J. Lipid Res.</source><year>2012</year><volume>53</volume><fpage>1117</fpage><lpage>1125</lpage><pub-id pub-id-type="doi">10.1194/jlr.M021485</pub-id><?supplied-pmid 22467681?><pub-id pub-id-type="pmid">22467681</pub-id></element-citation></ref><ref id="B26-ijms-18-01438"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tain</surname><given-names>Y.-L.</given-names></name><name><surname>Hsu</surname><given-names>C.-N.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name></person-group><article-title>PPARs link early life nutritional insults to later programmed hypertension and metabolic syndrome</article-title><source>Int. J. Mol. Sci.</source><year>2015</year><volume>17</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17010020</pub-id><?supplied-pmid 26712739?><pub-id pub-id-type="pmid">26712739</pub-id></element-citation></ref><ref id="B27-ijms-18-01438"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Yeon</surname><given-names>J.E.</given-names></name><name><surname>Ko</surname><given-names>E.J.</given-names></name><name><surname>Yoon</surname><given-names>E.L.</given-names></name><name><surname>Suh</surname><given-names>S.J.</given-names></name><name><surname>Kang</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>H.R.</given-names></name><name><surname>Kang</surname><given-names>S.H.</given-names></name><name><surname>Yoo</surname><given-names>Y.J.</given-names></name><name><surname>Je</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease</article-title><source>World J. Gastroenterol.</source><year>2015</year><volume>21</volume><fpage>12787</fpage><lpage>12799</lpage><pub-id pub-id-type="doi">10.3748/wjg.v21.i45.12787</pub-id><?supplied-pmid 26668503?><pub-id pub-id-type="pmid">26668503</pub-id></element-citation></ref><ref id="B28-ijms-18-01438"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltacio&#287;lu</surname><given-names>E.</given-names></name><name><surname>Akalin</surname><given-names>F. A.</given-names></name><name><surname>Alver</surname><given-names>A.</given-names></name><name><surname>De&#287;er</surname><given-names>O.</given-names></name><name><surname>Karabulut</surname><given-names>E.</given-names></name></person-group><article-title>Protein carbonyl levels in serum and gingival crevicular fluid in patients with chronic periodontitis</article-title><source>Arch. Oral Biol.</source><year>2008</year><volume>53</volume><fpage>716</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1016/j.archoralbio.2008.02.002</pub-id><?supplied-pmid 18346710?><pub-id pub-id-type="pmid">18346710</pub-id></element-citation></ref><ref id="B29-ijms-18-01438"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bull&#243;n</surname><given-names>P.</given-names></name><name><surname>Rom&#225;n-Malo</surname><given-names>L.</given-names></name><name><surname>Mar&#237;n-Aguilar</surname><given-names>F.</given-names></name><name><surname>Alvarez-Suarez</surname><given-names>J.M.</given-names></name><name><surname>Giampieri</surname><given-names>F.</given-names></name><name><surname>Battino</surname><given-names>M.</given-names></name><name><surname>Cordero</surname><given-names>M.D.</given-names></name></person-group><article-title>Lipophilic antioxidants prevent lipopolysaccharide-induced mitochondrial dysfunction through mitochondrial biogenesis improvement</article-title><source>Pharmacol. Res.</source><year>2015</year><volume>91</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2014.10.007</pub-id><?supplied-pmid 25447593?><pub-id pub-id-type="pmid">25447593</pub-id></element-citation></ref><ref id="B30-ijms-18-01438"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varela-Lopez</surname><given-names>A.</given-names></name><name><surname>Bullon</surname><given-names>P.</given-names></name><name><surname>Battino</surname><given-names>M.</given-names></name><name><surname>Ramirez-Tortosa</surname><given-names>M.C.</given-names></name><name><surname>Ochoa</surname><given-names>J.J.</given-names></name><name><surname>Cordero</surname><given-names>M.D.</given-names></name><name><surname>Ramirez-Tortosa</surname><given-names>C.L.</given-names></name><name><surname>Rubini</surname><given-names>C.</given-names></name><name><surname>Zizzi</surname><given-names>A.</given-names></name><name><surname>Quiles</surname><given-names>J.L.</given-names></name></person-group><article-title>Coenzyme Q Protects against age-related alveolar bone loss associated to n-6 polyunsaturated fatty acid rich-diets by modulating mitochondrial mechanisms</article-title><source>J. Gerontol. Ser. A Biol. Sci. Med. Sci.</source><year>2016</year><volume>71</volume><fpage>593</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1093/gerona/glv063</pub-id><?supplied-pmid 26219851?><pub-id pub-id-type="pmid">26219851</pub-id></element-citation></ref><ref id="B31-ijms-18-01438"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalik</surname><given-names>L.</given-names></name><name><surname>Auwerx</surname><given-names>J.</given-names></name><name><surname>Berger</surname><given-names>J.P.</given-names></name><name><surname>Chatterjee</surname><given-names>V.K.</given-names></name><name><surname>Glass</surname><given-names>C.K.</given-names></name><name><surname>Gonzalez</surname><given-names>F.J.</given-names></name><name><surname>Grimaldi</surname><given-names>P.A.</given-names></name><name><surname>Kadowaki</surname><given-names>T.</given-names></name><name><surname>Lazar</surname><given-names>M.A.</given-names></name><name><surname>Rahilly</surname><given-names>S.O.</given-names></name><etal/></person-group><article-title>International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors</article-title><source>Pharmacol. Rev.</source><year>2006</year><volume>58</volume><fpage>726</fpage><lpage>741</lpage><pub-id pub-id-type="doi">10.1124/pr.58.4.5</pub-id><?supplied-pmid 17132851?><pub-id pub-id-type="pmid">17132851</pub-id></element-citation></ref><ref id="B32-ijms-18-01438"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>J.H.</given-names></name><name><surname>Seo</surname><given-names>A.Y.</given-names></name><name><surname>Chung</surname><given-names>S.W.</given-names></name><name><surname>Kim</surname><given-names>M.K.</given-names></name><name><surname>Leeuwenburgh</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>B.P.</given-names></name><name><surname>Chung</surname><given-names>H.Y.</given-names></name></person-group><article-title>Molecular mechanism of PPAR in the regulation of age-related inflammation</article-title><source>Ageing Res. Rev.</source><year>2008</year><volume>7</volume><fpage>126</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.arr.2008.01.001</pub-id><?supplied-pmid 18313368?><pub-id pub-id-type="pmid">18313368</pub-id></element-citation></ref><ref id="B33-ijms-18-01438"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croasdell</surname><given-names>A.</given-names></name><name><surname>Duffney</surname><given-names>P.F.</given-names></name><name><surname>Kim</surname><given-names>N.</given-names></name><name><surname>Lacy</surname><given-names>S.H.</given-names></name><name><surname>Sime</surname><given-names>P.J.</given-names></name><name><surname>Phipps</surname><given-names>R.P.</given-names></name></person-group><article-title>PPAR&#947; and the innate immune system mediate the resolution of inflammation</article-title><source>PPAR Res.</source><year>2015</year><volume>2015</volume><fpage>549691</fpage><pub-id pub-id-type="doi">10.1155/2015/549691</pub-id><?supplied-pmid 26713087?><pub-id pub-id-type="pmid">26713087</pub-id></element-citation></ref><ref id="B34-ijms-18-01438"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalik</surname><given-names>L.</given-names></name><name><surname>Feige</surname><given-names>J.N.</given-names></name><name><surname>Gelman</surname><given-names>L.</given-names></name><name><surname>Pedrazzini</surname><given-names>T.</given-names></name><name><surname>Keller</surname><given-names>H.</given-names></name><name><surname>Desvergne</surname><given-names>B.</given-names></name><name><surname>Wahli</surname><given-names>W.</given-names></name></person-group><article-title>Selective expression of a dominant-negative form of peroxisome proliferator-activated receptor in keratinocytes leads to impaired epidermal healing</article-title><source>Mol. Endocrinol.</source><year>2005</year><volume>19</volume><fpage>2335</fpage><lpage>2348</lpage><pub-id pub-id-type="doi">10.1210/me.2005-0068</pub-id><?supplied-pmid 15890673?><pub-id pub-id-type="pmid">15890673</pub-id></element-citation></ref><ref id="B35-ijms-18-01438"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>N.S.</given-names></name></person-group><article-title>Critical roles of PPAR&#946;/&#948; in keratinocyte response to inflammation</article-title><source>Genes Dev.</source><year>2001</year><volume>15</volume><fpage>3263</fpage><lpage>3277</lpage><pub-id pub-id-type="doi">10.1101/gad.207501</pub-id><?supplied-pmid 11751632?><pub-id pub-id-type="pmid">11751632</pub-id></element-citation></ref><ref id="B36-ijms-18-01438"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iglesias</surname><given-names>J.</given-names></name><name><surname>Morales</surname><given-names>L.</given-names></name><name><surname>Barreto</surname><given-names>G.E.</given-names></name></person-group><article-title>Metabolic and inflammatory adaptation of reactive astrocytes: Role of PPARs</article-title><source>Mol. Neurobiol.</source><year>2017</year><volume>54</volume><fpage>2518</fpage><lpage>2538</lpage><pub-id pub-id-type="doi">10.1007/s12035-016-9833-2</pub-id><?supplied-pmid 26984740?><pub-id pub-id-type="pmid">26984740</pub-id></element-citation></ref><ref id="B37-ijms-18-01438"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desreumaux</surname><given-names>P.</given-names></name><name><surname>Dubuquoy</surname><given-names>L.</given-names></name><name><surname>Nutten</surname><given-names>S.</given-names></name><name><surname>Peuchmaur</surname><given-names>M.</given-names></name><name><surname>Englaro</surname><given-names>W.</given-names></name><name><surname>Schoonjans</surname><given-names>K.</given-names></name><name><surname>Derijard</surname><given-names>B.</given-names></name><name><surname>Desvergne</surname><given-names>B.</given-names></name><name><surname>Wahli</surname><given-names>W.</given-names></name><name><surname>Chambon</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome Proliferator-activated receptor &#947; (PPAR&#947;) heterodimer. A basis for new therapeutic strategies</article-title><source>J. Exp. Med.</source><year>2001</year><volume>193</volume><fpage>827</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1084/jem.193.7.827</pub-id><?supplied-pmid 11283155?><pub-id pub-id-type="pmid">11283155</pub-id></element-citation></ref><ref id="B38-ijms-18-01438"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>R.M.</given-names></name></person-group><article-title>The steroid and thyroid hormone receptor superfamily</article-title><source>Science</source><year>1988</year><volume>240</volume><fpage>889</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1126/science.3283939</pub-id><?supplied-pmid 3283939?><pub-id pub-id-type="pmid">3283939</pub-id></element-citation></ref><ref id="B39-ijms-18-01438"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delerive</surname><given-names>P.</given-names></name><name><surname>de Bosscher</surname><given-names>K.</given-names></name><name><surname>Besnard</surname><given-names>S.</given-names></name><name><surname>Vanden Berghe</surname><given-names>W.</given-names></name><name><surname>Peters</surname><given-names>J.M.</given-names></name><name><surname>Gonzalez</surname><given-names>F.J.</given-names></name><name><surname>Fruchart</surname><given-names>J.C.</given-names></name><name><surname>Tedgui</surname><given-names>A.</given-names></name><name><surname>Haegeman</surname><given-names>G.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptor &#945; negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-&#954;B and AP-1</article-title><source>J. Biol. Chem.</source><year>1999</year><volume>274</volume><fpage>32048</fpage><lpage>32054</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.45.32048</pub-id><?supplied-pmid 10542237?><pub-id pub-id-type="pmid">10542237</pub-id></element-citation></ref><ref id="B40-ijms-18-01438"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Paola</surname><given-names>R.</given-names></name><name><surname>Briguglio</surname><given-names>F.</given-names></name><name><surname>Paterniti</surname><given-names>I.</given-names></name><name><surname>Mazzon</surname><given-names>E.</given-names></name><name><surname>Oteri</surname><given-names>G.</given-names></name><name><surname>Militi</surname><given-names>D.</given-names></name><name><surname>Cordasco</surname><given-names>G.</given-names></name><name><surname>Cuzzocrea</surname><given-names>S.</given-names></name></person-group><article-title>Emerging role of PPAR&#946;/&#948; in inflammatory process associated to experimental periodontitis</article-title><source>Mediat. Inflamm.</source><year>2011</year><volume>2011</volume><fpage>787159</fpage><pub-id pub-id-type="doi">10.1155/2011/787159</pub-id><?supplied-pmid 22131647?><pub-id pub-id-type="pmid">22131647</pub-id></element-citation></ref><ref id="B41-ijms-18-01438"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Yi</surname><given-names>T.</given-names></name><name><surname>Yun</surname><given-names>J.-H.</given-names></name></person-group><article-title>Maintained stemness of human periodontal ligament stem cells isolated following prolonged storage of extracted teeth</article-title><source>J. Periodontol.</source><year>2016</year><volume>87</volume><fpage>e148</fpage><lpage>e158</lpage><pub-id pub-id-type="doi">10.1902/jop.2016.150693</pub-id><?supplied-pmid 26889590?><pub-id pub-id-type="pmid">26889590</pub-id></element-citation></ref><ref id="B42-ijms-18-01438"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrukhov</surname><given-names>O.</given-names></name><name><surname>Ertlschweiger</surname><given-names>S.</given-names></name><name><surname>Moritz</surname><given-names>A.</given-names></name><name><surname>Bantleon</surname><given-names>H.-P.</given-names></name><name><surname>Rausch-Fan</surname><given-names>X.</given-names></name></person-group><article-title>Different effects of <italic>P. gingivalis</italic> LPS and <italic>E. coli</italic> LPS on the expression of interleukin-6 in human gingival fibroblasts</article-title><source>Acta Odontol. Scand.</source><year>2014</year><volume>72</volume><fpage>337</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.3109/00016357.2013.834535</pub-id><?supplied-pmid 24255960?><pub-id pub-id-type="pmid">24255960</pub-id></element-citation></ref><ref id="B43-ijms-18-01438"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>F.</given-names></name><name><surname>Hao</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name></person-group><article-title>SUMOylation of PPAR&#947; by rosiglitazone prevents LPS-induced NCoR degradation mediating down regulation of chemokines expression in renal proximal tubular cells</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e79815</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0079815</pub-id><?supplied-pmid 24260304?><pub-id pub-id-type="pmid">24260304</pub-id></element-citation></ref><ref id="B44-ijms-18-01438"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Fu</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name></person-group><article-title>Preventive effects of protocatechuic acid on LPS-induced inflammatory response in human gingival fibroblasts via activating PPAR&#947;</article-title><source>Inflammation</source><year>2015</year><volume>38</volume><fpage>1080</fpage><lpage>1084</lpage><pub-id pub-id-type="doi">10.1007/s10753-014-0073-1</pub-id><?supplied-pmid 25433806?><pub-id pub-id-type="pmid">25433806</pub-id></element-citation></ref><ref id="B45-ijms-18-01438"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Paola</surname><given-names>R.</given-names></name><name><surname>Mazzon</surname><given-names>E.</given-names></name><name><surname>Maiere</surname><given-names>D.</given-names></name><name><surname>Zito</surname><given-names>D.</given-names></name><name><surname>Britti</surname><given-names>D.</given-names></name><name><surname>de Majo</surname><given-names>M.</given-names></name><name><surname>Genovese</surname><given-names>T.</given-names></name><name><surname>Cuzzocrea</surname><given-names>S.</given-names></name></person-group><article-title>Rosiglitazone reduces the evolution of experimental periodontitis in the rat</article-title><source>J. Dent. Res.</source><year>2006</year><volume>85</volume><fpage>156</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1177/154405910608500208</pub-id><?supplied-pmid 16434734?><pub-id pub-id-type="pmid">16434734</pub-id></element-citation></ref><ref id="B46-ijms-18-01438"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folwaczny</surname><given-names>M.</given-names></name><name><surname>Manolis</surname><given-names>V.</given-names></name><name><surname>Markus</surname><given-names>C.</given-names></name><name><surname>Glas</surname><given-names>J.</given-names></name></person-group><article-title>Variants of the human PPARG locus and the susceptibility to chronic periodontitis</article-title><source>Innate Immun.</source><year>2011</year><volume>17</volume><fpage>541</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1177/1753425910392089</pub-id><?supplied-pmid 21252350?><pub-id pub-id-type="pmid">21252350</pub-id></element-citation></ref><ref id="B47-ijms-18-01438"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname><given-names>E.</given-names></name><name><surname>Sugita</surname><given-names>N.</given-names></name><name><surname>Kikuchi</surname><given-names>A.</given-names></name><name><surname>Shimada</surname><given-names>Y.</given-names></name><name><surname>Sasahara</surname><given-names>J.</given-names></name><name><surname>Iwanaga</surname><given-names>R.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Yoshie</surname><given-names>H.</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptor gamma polymorphism and periodontitis in pregnant Japanese women</article-title><source>J. Periodontol.</source><year>2010</year><volume>81</volume><fpage>897</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1902/jop.2010.090669</pub-id><?supplied-pmid 20450366?><pub-id pub-id-type="pmid">20450366</pub-id></element-citation></ref><ref id="B48-ijms-18-01438"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshihara</surname><given-names>A.</given-names></name><name><surname>Sugita</surname><given-names>N.</given-names></name><name><surname>Iwasaki</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Miyazaki</surname><given-names>H.</given-names></name><name><surname>Yoshie</surname><given-names>H.</given-names></name><name><surname>Nakamura</surname><given-names>K.</given-names></name></person-group><article-title>The interaction between &#946;-3 adrenergic receptor and peroxisome proliferator-activated receptor gamma gene polymorphism to periodontal disease in community-dwelling elderly japanese</article-title><source>J. Periodontol.</source><year>2015</year><volume>86</volume><fpage>955</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1902/jop.2015.140472</pub-id><?supplied-pmid 25855572?><pub-id pub-id-type="pmid">25855572</pub-id></element-citation></ref><ref id="B49-ijms-18-01438"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Sugita</surname><given-names>N.</given-names></name><name><surname>Yoshihara</surname><given-names>A.</given-names></name><name><surname>Iwasaki</surname><given-names>M.</given-names></name><name><surname>Miyazaki</surname><given-names>H.</given-names></name><name><surname>Nakamura</surname><given-names>K.</given-names></name><name><surname>Yoshie</surname><given-names>H.</given-names></name></person-group><article-title>PPAR&#947; gene polymorphism, C-reactive protein level, BMI and periodontitis in post-menopausal Japanese women</article-title><source>Gerodontology</source><year>2014</year><volume>33</volume><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1111/ger.12110</pub-id><?supplied-pmid 24494816?><pub-id pub-id-type="pmid">24494816</pub-id></element-citation></ref><ref id="B50-ijms-18-01438"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briguglio</surname><given-names>E.</given-names></name><name><surname>di Paola</surname><given-names>R.</given-names></name><name><surname>Paterniti</surname><given-names>I.</given-names></name><name><surname>Mazzon</surname><given-names>E.</given-names></name><name><surname>Oteri</surname><given-names>G.</given-names></name><name><surname>Cordasco</surname><given-names>G.</given-names></name><name><surname>Cuzzocrea</surname><given-names>S.</given-names></name></person-group><article-title>WY-14643, a potent peroxisome proliferator activator receptor-&#945; PPAR&#945; agonist ameliorates the inflammatory process associated to experimental periodontitis</article-title><source>PPAR Res.</source><year>2010</year><volume>2010</volume><fpage>193019</fpage><pub-id pub-id-type="doi">10.1155/2010/193019</pub-id><?supplied-pmid 21253492?><pub-id pub-id-type="pmid">21253492</pub-id></element-citation></ref><ref id="B51-ijms-18-01438"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harsl&#248;f</surname><given-names>T.</given-names></name><name><surname>Tofteng</surname><given-names>C.L.</given-names></name><name><surname>Husted</surname><given-names>L.B.</given-names></name><name><surname>Nyegaard</surname><given-names>M.</given-names></name><name><surname>B&#248;rglum</surname><given-names>A.</given-names></name><name><surname>Carstens</surname><given-names>M.</given-names></name><name><surname>Stenkj&#230;r</surname><given-names>L.</given-names></name><name><surname>Brixen</surname><given-names>K.</given-names></name><name><surname>Eiken</surname><given-names>P.</given-names></name><name><surname>Jensen</surname><given-names>J.-E.B.</given-names></name><etal/></person-group><article-title>Polymorphisms of the peroxisome proliferator-activated receptor &#947; (PPAR&#947;) gene are associated with osteoporosis</article-title><source>Osteoporos. Int.</source><year>2011</year><volume>22</volume><fpage>2655</fpage><lpage>2666</lpage><pub-id pub-id-type="doi">10.1007/s00198-010-1491-z</pub-id><?supplied-pmid 21104228?><pub-id pub-id-type="pmid">21104228</pub-id></element-citation></ref><ref id="B52-ijms-18-01438"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>Y.</given-names></name><name><surname>Chong</surname><given-names>L.-W.</given-names></name><name><surname>Evans</surname><given-names>R.M.</given-names></name></person-group><article-title>PPAR&#947; regulates osteoclastogenesis in mice</article-title><source>Nat. Med.</source><year>2007</year><volume>13</volume><fpage>1496</fpage><lpage>1503</lpage><pub-id pub-id-type="doi">10.1038/nm1672</pub-id><?supplied-pmid 18059282?><pub-id pub-id-type="pmid">18059282</pub-id></element-citation></ref><ref id="B53-ijms-18-01438"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.-J.</given-names></name><name><surname>Yoon</surname><given-names>K.-A.</given-names></name><name><surname>Yoon</surname><given-names>H.-J.</given-names></name><name><surname>Hong</surname><given-names>J.M.</given-names></name><name><surname>Lee</surname><given-names>M.-J.</given-names></name><name><surname>Lee</surname><given-names>I.-K.</given-names></name><name><surname>Kim</surname><given-names>S.-Y.</given-names></name></person-group><article-title>Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-&#954;B activity and c-Fos induction and prevents inflammatory bone loss in mice</article-title><source>J. Leukoc. Biol.</source><year>2013</year><volume>94</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1189/jlb.1112601</pub-id><?supplied-pmid 23657115?><pub-id pub-id-type="pmid">23657115</pub-id></element-citation></ref><ref id="B54-ijms-18-01438"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddhivarn</surname><given-names>C.</given-names></name><name><surname>Banes</surname><given-names>A.</given-names></name><name><surname>Champagne</surname><given-names>C.</given-names></name><name><surname>Riche</surname><given-names>E.L.</given-names></name><name><surname>Weerapradist</surname><given-names>W.</given-names></name><name><surname>Offenbacher</surname><given-names>S.</given-names></name></person-group><article-title>Prostaglandin D2 pathway and peroxisome proliferator-activated receptor &#947;-1 expression are induced by mechanical loading in an osteoblastic cell line</article-title><source>J. Periodontal Res.</source><year>2006</year><volume>41</volume><fpage>92</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0765.2005.00834.x</pub-id><?supplied-pmid 16499711?><pub-id pub-id-type="pmid">16499711</pub-id></element-citation></ref><ref id="B55-ijms-18-01438"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddhivarn</surname><given-names>C.</given-names></name><name><surname>Banes</surname><given-names>A.</given-names></name><name><surname>Champagne</surname><given-names>C.</given-names></name><name><surname>Rich&#233;</surname><given-names>E.L.</given-names></name><name><surname>Weerapradist</surname><given-names>W.</given-names></name><name><surname>Offenbacher</surname><given-names>S.</given-names></name></person-group><article-title>Mechanical loading and &#916;12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor &#947;-1, and bone nodule formation in an osteoblastic cell line</article-title><source>J. Periodontal Res.</source><year>2007</year><volume>42</volume><fpage>383</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0765.2006.00965.x</pub-id><?supplied-pmid 17760815?><pub-id pub-id-type="pmid">17760815</pub-id></element-citation></ref><ref id="B56-ijms-18-01438"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>W.-K.</given-names></name><name><surname>Park</surname><given-names>I.-S.</given-names></name><name><surname>Park</surname><given-names>S.-J.</given-names></name><name><surname>Yea</surname><given-names>S.S.</given-names></name><name><surname>Choi</surname><given-names>Y.H.</given-names></name><name><surname>Oh</surname><given-names>S.</given-names></name><name><surname>Park</surname><given-names>S.-G.</given-names></name><name><surname>Choi</surname><given-names>I.-W.</given-names></name></person-group><article-title>The 15-deoxy-&#916;12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-&#954;B activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1</article-title><source>Life Sci.</source><year>2009</year><volume>85</volume><fpage>46</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2009.04.010</pub-id><?supplied-pmid 19409914?><pub-id pub-id-type="pmid">19409914</pub-id></element-citation></ref><ref id="B57-ijms-18-01438"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan-Calanan</surname><given-names>R.M.</given-names></name><name><surname>Genco</surname><given-names>R.J.</given-names></name><name><surname>Wilding</surname><given-names>G.E.</given-names></name><name><surname>Hovey</surname><given-names>K.M.</given-names></name><name><surname>Trevisan</surname><given-names>M.</given-names></name><name><surname>Wactawski-Wende</surname><given-names>J.</given-names></name></person-group><article-title>Osteoporosis and oral infection: Independent risk factors for oral bone loss</article-title><source>J. Dent. Res.</source><year>2008</year><volume>87</volume><fpage>323</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1177/154405910808700403</pub-id><?supplied-pmid 18362312?><pub-id pub-id-type="pmid">18362312</pub-id></element-citation></ref><ref id="B58-ijms-18-01438"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Habashneh</surname><given-names>R.</given-names></name><name><surname>Alchalabi</surname><given-names>H.</given-names></name><name><surname>Khader</surname><given-names>Y.S.</given-names></name><name><surname>Hazza&#8217;a</surname><given-names>A.M.</given-names></name><name><surname>Odat</surname><given-names>Z.</given-names></name><name><surname>Johnson</surname><given-names>G.K.</given-names></name></person-group><article-title>Association between periodontal disease and osteoporosis in postmenopausal women in Jordan</article-title><source>J. Periodontol.</source><year>2010</year><volume>81</volume><fpage>1613</fpage><lpage>1621</lpage><pub-id pub-id-type="doi">10.1902/jop.2010.100190</pub-id><?supplied-pmid 20681809?><pub-id pub-id-type="pmid">20681809</pub-id></element-citation></ref><ref id="B59-ijms-18-01438"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepelassi</surname><given-names>E.</given-names></name><name><surname>Nicopoulou-Karayianni</surname><given-names>K.</given-names></name><name><surname>Archontopoulou</surname><given-names>A.D.</given-names></name><name><surname>Mitsea</surname><given-names>A.</given-names></name><name><surname>Kavadella</surname><given-names>A.</given-names></name><name><surname>Tsiklakis</surname><given-names>K.</given-names></name><name><surname>Vrotsos</surname><given-names>I.</given-names></name><name><surname>Devlin</surname><given-names>H.</given-names></name><name><surname>Horner</surname><given-names>K.</given-names></name></person-group><article-title>The relationship between osteoporosis and periodontitis in women aged 45&#8211;70 years</article-title><source>Oral Dis.</source><year>2012</year><volume>18</volume><fpage>353</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1111/j.1601-0825.2011.01881.x</pub-id><?supplied-pmid 22151499?><pub-id pub-id-type="pmid">22151499</pub-id></element-citation></ref><ref id="B60-ijms-18-01438"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshihara</surname><given-names>A.</given-names></name><name><surname>Seida</surname><given-names>Y.</given-names></name><name><surname>Hanada</surname><given-names>N.</given-names></name><name><surname>Miyazaki</surname><given-names>H.</given-names></name></person-group><article-title>A longitudinal study of the relationship between periodontal disease and bone mineral density in community-dwelling older adults</article-title><source>J. Clin. Periodontol.</source><year>2004</year><volume>31</volume><fpage>680</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1111/j.1600-051X.2004.00548.x</pub-id><?supplied-pmid 15257747?><pub-id pub-id-type="pmid">15257747</pub-id></element-citation></ref><ref id="B61-ijms-18-01438"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassumi</surname><given-names>M.Y.</given-names></name><name><surname>Silva-Filho</surname><given-names>V.J.</given-names></name><name><surname>Campos-J&#250;nior</surname><given-names>J.C.</given-names></name><name><surname>Vieira</surname><given-names>S.M.</given-names></name><name><surname>Cunha</surname><given-names>F.Q.</given-names></name><name><surname>Alves</surname><given-names>P.M.</given-names></name><name><surname>Alves</surname><given-names>J.B.</given-names></name><name><surname>Kawai</surname><given-names>T.</given-names></name><name><surname>Gon&#231;alves</surname><given-names>R.B.</given-names></name><name><surname>Napimoga</surname><given-names>M.H.</given-names></name></person-group><article-title>PPAR&#947; agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis</article-title><source>Int. Immunopharmacol.</source><year>2009</year><volume>9</volume><fpage>1150</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2009.06.002</pub-id><?supplied-pmid 19508902?><pub-id pub-id-type="pmid">19508902</pub-id></element-citation></ref><ref id="B62-ijms-18-01438"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Sugita</surname><given-names>N.</given-names></name><name><surname>Yoshihara</surname><given-names>A.</given-names></name><name><surname>Iwasaki</surname><given-names>M.</given-names></name><name><surname>Miyazaki</surname><given-names>H.</given-names></name><name><surname>Nakamura</surname><given-names>K.</given-names></name><name><surname>Yoshie</surname><given-names>H.</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptor (PPAR)&#947; polymorphism, vitamin d, bone mineral density and periodontitis in postmenopausal women</article-title><source>Oral Dis.</source><year>2013</year><volume>19</volume><fpage>501</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1111/odi.12032</pub-id><?supplied-pmid 23107193?><pub-id pub-id-type="pmid">23107193</pub-id></element-citation></ref><ref id="B63-ijms-18-01438"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattarai</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>Y.H.</given-names></name><name><surname>Lee</surname><given-names>N.H.</given-names></name><name><surname>Park</surname><given-names>I.S.</given-names></name><name><surname>Lee</surname><given-names>M.H.</given-names></name><name><surname>Yi</surname><given-names>H.K.</given-names></name></person-group><article-title>PPAR&#947; delivered by Ch-GNPs onto titanium surfaces inhibits implant-induced inflammation and induces bone mineralization of MC-3T3E1 osteoblast-like cells</article-title><source>Clin. Oral Implant. Res.</source><year>2013</year><volume>24</volume><fpage>1101</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0501.2012.02517.x</pub-id><?supplied-pmid 22713176?><pub-id pub-id-type="pmid">22713176</pub-id></element-citation></ref><ref id="B64-ijms-18-01438"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullon</surname><given-names>P.</given-names></name><name><surname>Newman</surname><given-names>H.N.</given-names></name><name><surname>Battino</surname><given-names>M.</given-names></name></person-group><article-title>Obesity, diabetes mellitus, atherosclerosis and chronic periodontitis: A shared pathology via oxidative stress and mitochondrial dysfunction?</article-title><source>Periodontol. 2000</source><year>2014</year><volume>64</volume><fpage>139</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0757.2012.00455.x</pub-id><?supplied-pmid 24320961?><pub-id pub-id-type="pmid">24320961</pub-id></element-citation></ref><ref id="B65-ijms-18-01438"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dandona</surname><given-names>P.</given-names></name><name><surname>Aljada</surname><given-names>A.</given-names></name><name><surname>Bandyopadhyay</surname><given-names>A.</given-names></name></person-group><article-title>Inflammation: The link between insulin resistance, obesity and diabetes</article-title><source>Trends Immunol.</source><year>2004</year><volume>25</volume><fpage>4</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.it.2003.10.013</pub-id><?supplied-pmid 14698276?><pub-id pub-id-type="pmid">14698276</pub-id></element-citation></ref><ref id="B66-ijms-18-01438"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinaudo</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name></person-group><article-title>Fetal programming and metabolic syndrome</article-title><source>Annu. Rev. Physiol.</source><year>2012</year><volume>74</volume><fpage>107</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-020911-153245</pub-id><?supplied-pmid 21910625?><pub-id pub-id-type="pmid">21910625</pub-id></element-citation></ref><ref id="B67-ijms-18-01438"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lendvai</surname><given-names>A.</given-names></name><name><surname>Deutsch</surname><given-names>M.J.</given-names></name><name><surname>Plosch</surname><given-names>T.</given-names></name><name><surname>Ensenauer</surname><given-names>R.</given-names></name></person-group><article-title>The peroxisome proliferator-activated receptors under epigenetic control in placental metabolism and fetal development</article-title><source>Am. J. Physiol. Endocrinol. Metab.</source><year>2016</year><volume>310</volume><fpage>E797</fpage><lpage>E810</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00372.2015</pub-id><?supplied-pmid 26860983?><pub-id pub-id-type="pmid">26860983</pub-id></element-citation></ref><ref id="B68-ijms-18-01438"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monsalve</surname><given-names>F.A.</given-names></name><name><surname>Pyarasani</surname><given-names>R.D.</given-names></name><name><surname>Delgado-Lopez</surname><given-names>F.</given-names></name><name><surname>Moore-Carrasco</surname><given-names>R.</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases</article-title><source>Mediat. Inflamm.</source><year>2013</year><volume>2013</volume><fpage>549627</fpage><pub-id pub-id-type="doi">10.1155/2013/549627</pub-id><?supplied-pmid 23781121?><pub-id pub-id-type="pmid">23781121</pub-id></element-citation></ref><ref id="B69-ijms-18-01438"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yessoufou</surname><given-names>A.</given-names></name><name><surname>Wahli</surname><given-names>W.</given-names></name></person-group><article-title>Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels</article-title><source>Swiss Med. Wkly.</source><year>2010</year><volume>140</volume><fpage>w13071</fpage><pub-id pub-id-type="doi">10.4414/smw.2010.13071</pub-id><?supplied-pmid 20842602?><pub-id pub-id-type="pmid">20842602</pub-id></element-citation></ref><ref id="B70-ijms-18-01438"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emilsson</surname><given-names>V.</given-names></name><name><surname>Thorleifsson</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Leonardson</surname><given-names>A.S.</given-names></name><name><surname>Zink</surname><given-names>F.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Carlson</surname><given-names>S.</given-names></name><name><surname>Helgason</surname><given-names>A.</given-names></name><name><surname>Walters</surname><given-names>G.B.</given-names></name><name><surname>Gunnarsdottir</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Genetics of gene expression and its effect on disease</article-title><source>Nature</source><year>2008</year><volume>452</volume><fpage>423</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1038/nature06758</pub-id><?supplied-pmid 18344981?><pub-id pub-id-type="pmid">18344981</pub-id></element-citation></ref><ref id="B71-ijms-18-01438"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Q.</given-names></name><name><surname>Gao</surname><given-names>Z.</given-names></name><name><surname>Alarcon</surname><given-names>R.M.</given-names></name><name><surname>Ye</surname><given-names>J.</given-names></name><name><surname>Yun</surname><given-names>Z.</given-names></name></person-group><article-title>A role of miR-27 in the regulation of adipogenesis</article-title><source>FEBS J.</source><year>2009</year><volume>276</volume><fpage>2348</fpage><lpage>2358</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.06967.x</pub-id><?supplied-pmid 19348006?><pub-id pub-id-type="pmid">19348006</pub-id></element-citation></ref><ref id="B72-ijms-18-01438"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takanabe</surname><given-names>R.</given-names></name><name><surname>Ono</surname><given-names>K.</given-names></name><name><surname>Abe</surname><given-names>Y.</given-names></name><name><surname>Takaya</surname><given-names>T.</given-names></name><name><surname>Horie</surname><given-names>T.</given-names></name><name><surname>Wada</surname><given-names>H.</given-names></name><name><surname>Kita</surname><given-names>T.</given-names></name><name><surname>Satoh</surname><given-names>N.</given-names></name><name><surname>Shimatsu</surname><given-names>A.</given-names></name><name><surname>Hasegawa</surname><given-names>K.</given-names></name></person-group><article-title>Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2008</year><volume>376</volume><fpage>728</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.09.050</pub-id><?supplied-pmid 18809385?><pub-id pub-id-type="pmid">18809385</pub-id></element-citation></ref><ref id="B73-ijms-18-01438"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>A.</given-names></name><name><surname>Gohda</surname><given-names>T.</given-names></name><name><surname>Funabiki</surname><given-names>K.</given-names></name><name><surname>Horikoshi</surname><given-names>S.</given-names></name><name><surname>Tomino</surname><given-names>Y.</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptor&#8239;&#947; gene polymorphism is associated with serum triglyceride levels and body mass index in Japanese type 2 diabetic patients</article-title><source>J. Clin. Lab. Anal.</source><year>2004</year><volume>18</volume><fpage>317</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1002/jcla.20045</pub-id><?supplied-pmid 15543562?><pub-id pub-id-type="pmid">15543562</pub-id></element-citation></ref><ref id="B74-ijms-18-01438"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garaulet</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>C.E.</given-names></name><name><surname>Hern&#225;ndez-Gonz&#225;lez</surname><given-names>T.</given-names></name><name><surname>Lee</surname><given-names>Y.-C.</given-names></name><name><surname>Ordov&#225;s</surname><given-names>J.M.</given-names></name></person-group><article-title>PPAR&#947; Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet</article-title><source>Mol. Nutr. Food Res.</source><year>2011</year><volume>55</volume><fpage>1771</fpage><lpage>1779</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201100437</pub-id><?supplied-pmid 22102511?><pub-id pub-id-type="pmid">22102511</pub-id></element-citation></ref><ref id="B75-ijms-18-01438"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#252;hl</surname><given-names>R.</given-names></name><name><surname>Landrier</surname><given-names>J.F.</given-names></name></person-group><article-title>Dietary regulation of adiponectin by direct and indirect lipid activators of nuclear hormone receptors</article-title><source>Mol. Nutr. Food Res.</source><year>2016</year><volume>60</volume><fpage>175</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201500619</pub-id><?supplied-pmid 26610729?><pub-id pub-id-type="pmid">26610729</pub-id></element-citation></ref><ref id="B76-ijms-18-01438"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>G.</given-names></name><name><surname>Cheng</surname><given-names>L.</given-names></name><name><surname>Qin</surname><given-names>Q.</given-names></name><name><surname>Frontin</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name></person-group><article-title>PPAR&#948; modulates lipopolysaccharide-induced TNF-&#945; inflammation signaling in cultured cardiomyocytes</article-title><source>J. Mol. Cell. Cardiol.</source><year>2006</year><volume>40</volume><fpage>821</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2006.03.422</pub-id><?supplied-pmid 16698033?><pub-id pub-id-type="pmid">16698033</pub-id></element-citation></ref><ref id="B77-ijms-18-01438"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palomer</surname><given-names>X.</given-names></name><name><surname>Barroso</surname><given-names>E.</given-names></name><name><surname>Zarei</surname><given-names>M.</given-names></name><name><surname>Botteri</surname><given-names>G.</given-names></name><name><surname>V&#225;zquez-Carrera</surname><given-names>M.</given-names></name></person-group><article-title>PPAR&#946;/&#948; and lipid metabolism in the heart</article-title><source>Biochim. Biophys. Acta</source><year>2016</year><volume>1861</volume><fpage>1569</fpage><lpage>1578</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2016.01.019</pub-id><?supplied-pmid 26825692?><pub-id pub-id-type="pmid">26825692</pub-id></element-citation></ref><ref id="B78-ijms-18-01438"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andriankaja</surname><given-names>O.M.</given-names></name><name><surname>Galicia</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>G.</given-names></name><name><surname>Xiao</surname><given-names>W.</given-names></name><name><surname>Alawi</surname><given-names>F.</given-names></name><name><surname>Graves</surname><given-names>D.T.</given-names></name></person-group><article-title>Gene expression dynamics during diabetic periodontitis</article-title><source>J. Dent. Res.</source><year>2012</year><volume>91</volume><fpage>1160</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1177/0022034512465292</pub-id><?supplied-pmid 23103632?><pub-id pub-id-type="pmid">23103632</pub-id></element-citation></ref><ref id="B79-ijms-18-01438"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvi</surname><given-names>G.E.</given-names></name><name><surname>Beck</surname><given-names>J.D.</given-names></name><name><surname>Offenbacher</surname><given-names>S.</given-names></name></person-group><article-title>PGE2, IL-1&#946;, and TNF-&#945; responses in diabetics as modifiers of periodontal disease expression</article-title><source>Ann. Periodontol.</source><year>1998</year><volume>3</volume><fpage>40</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1902/annals.1998.3.1.40</pub-id><?supplied-pmid 9722689?><pub-id pub-id-type="pmid">9722689</pub-id></element-citation></ref><ref id="B80-ijms-18-01438"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nareika</surname><given-names>A.</given-names></name><name><surname>Maldonado</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Game</surname><given-names>B.A.</given-names></name><name><surname>Slate</surname><given-names>E.H.</given-names></name><name><surname>Sanders</surname><given-names>J.J.</given-names></name><name><surname>London</surname><given-names>S.D.</given-names></name><name><surname>Lopes-Virella</surname><given-names>M.F.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name></person-group><article-title>High glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin</article-title><source>J. Periodontal Res.</source><year>2007</year><volume>42</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0765.2006.00911.x</pub-id><?supplied-pmid 17214637?><pub-id pub-id-type="pmid">17214637</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="ijms-18-01438-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>(<bold>a</bold>) Healthy periodontium: gingiva (G), periodontal ligament (L), root cementum (C) and alveolar bone (B); (<bold>b</bold>) Gingivitis; there is presence of calculus (DC). The inflammation is reversible; and (<bold>c</bold>) Severe form of chronic periodontitis: gingival inflammation, depth pocket, subgingival calculus and mobility.</p></caption><graphic xlink:href="ijms-18-01438-g001"/></fig><fig id="ijms-18-01438-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Anti-inflammatory effect of peroxisome proliferator-activated receptors &#947; (PPAR&#947;). A rat model of ligature-induced periodontitis shows the effects of WY14643, a potent peroxisome proliferator activator receptor &#945; (PPAR&#945;) agonist. The treatment with WY14643 attenuates the degree of inflammatory response in the gingival tissues. All of these data support that PPAR&#945; has a pernicious role in the development of damage associated with periodontitis in rats [<xref rid="B50-ijms-18-01438" ref-type="bibr">50</xref>]. TNF-&#945;, tumor necrosis factor-&#945;; IL-1&#946;, interleukin 1 &#946;; IL-6, interleukin 6; IL-8, interleukin 8; and LPS, lipopolysaccharide.</p></caption><graphic xlink:href="ijms-18-01438-g002"/></fig></floats-group></article>